504 related articles for article (PubMed ID: 17581492)
1. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.
Garnacho-Montero J; Sa-Borges M; Sole-Violan J; Barcenilla F; Escoresca-Ortega A; Ochoa M; Cayuela A; Rello J
Crit Care Med; 2007 Aug; 35(8):1888-95. PubMed ID: 17581492
[TBL] [Abstract][Full Text] [Related]
2. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
3. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia.
Agbaht K; Diaz E; Muñoz E; Lisboa T; Gomez F; Depuydt PO; Blot SI; Rello J
Crit Care Med; 2007 Sep; 35(9):2064-70. PubMed ID: 17581489
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia.
Heyland DK; Dodek P; Muscedere J; Day A; Cook D;
Crit Care Med; 2008 Mar; 36(3):737-44. PubMed ID: 18091545
[TBL] [Abstract][Full Text] [Related]
5. Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock.
Rodríguez A; Mendia A; Sirvent JM; Barcenilla F; de la Torre-Prados MV; Solé-Violán J; Rello J;
Crit Care Med; 2007 Jun; 35(6):1493-8. PubMed ID: 17452932
[TBL] [Abstract][Full Text] [Related]
6. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia.
Lisboa T; Seligman R; Diaz E; Rodriguez A; Teixeira PJ; Rello J
Crit Care Med; 2008 Jan; 36(1):166-71. PubMed ID: 18007271
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of monotherapy in the treatment of Pseudomonas ventilator-associated pneumonia in patients with trauma.
Magnotti LJ; Schroeppel TJ; Clement LP; Swanson JM; Bee TK; Maish GO; Minard G; Zarzaur BL; Fischer PE; Fabian TC; Croce MA
J Trauma; 2009 Apr; 66(4):1052-8; discussion 1058-9. PubMed ID: 19359914
[TBL] [Abstract][Full Text] [Related]
9. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse.
Leone M; Garcin F; Bouvenot J; Boyadjev I; Visintini P; Albanèse J; Martin C
Crit Care Med; 2007 Feb; 35(2):379-85; quizz 386. PubMed ID: 17205011
[TBL] [Abstract][Full Text] [Related]
10. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
Shorr AF; Combes A; Kollef MH; Chastre J
Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
[TBL] [Abstract][Full Text] [Related]
11. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.
Nicasio AM; Eagye KJ; Kuti EL; Nicolau DP; Kuti JL
Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997
[TBL] [Abstract][Full Text] [Related]
12. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes.
Parker CM; Kutsogiannis J; Muscedere J; Cook D; Dodek P; Day AG; Heyland DK;
J Crit Care; 2008 Mar; 23(1):18-26. PubMed ID: 18359417
[TBL] [Abstract][Full Text] [Related]
13. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.
Gruson D; Hilbert G; Vargas F; Valentino R; Bui N; Pereyre S; Bebear C; Bebear CM; Gbikpi-Benissan G
Crit Care Med; 2003 Jul; 31(7):1908-14. PubMed ID: 12847382
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia.
Nicasio AM; Eagye KJ; Nicolau DP; Shore E; Palter M; Pepe J; Kuti JL
J Crit Care; 2010 Mar; 25(1):69-77. PubMed ID: 19427167
[TBL] [Abstract][Full Text] [Related]
15. Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia.
Eagye KJ; Nicolau DP; Kuti JL
Semin Respir Crit Care Med; 2009 Feb; 30(1):116-23. PubMed ID: 19199193
[TBL] [Abstract][Full Text] [Related]
16. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
17. Impact of combination therapy and early de-escalation on outcome of ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
Deconinck L; Meybeck A; Patoz P; Van Grunderbeeck N; Boussekey N; Chiche A; Delannoy PY; Georges H; Leroy O
Infect Dis (Lond); 2017 May; 49(5):396-404. PubMed ID: 28092204
[TBL] [Abstract][Full Text] [Related]
18. Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis.
Kuti EL; Patel AA; Coleman CI
J Crit Care; 2008 Mar; 23(1):91-100. PubMed ID: 18359426
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
[TBL] [Abstract][Full Text] [Related]
20. Cost of Gram-negative resistance.
Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
